Precision Biosciences Stock Performance

DTIL Stock  USD 3.96  0.03  0.75%   
The company holds a Beta of 0.8, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Precision BioSciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Precision BioSciences is expected to be smaller as well. At this point, Precision BioSciences has a negative expected return of -0.93%. Please make sure to check Precision BioSciences' total risk alpha, as well as the relationship between the skewness and day median price , to decide if Precision BioSciences performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Precision BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in March 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more

Actual Historical Performance (%)

One Day Return
(0.63)
Five Day Return
(6.38)
Year To Date Return
(3.41)
Ten Year Return
(99.24)
All Time Return
(99.24)
Last Split Factor
1:30
Last Split Date
2024-02-14
1
Precision BioSciences Announces 75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants
11/10/2025
2
How Precision BioSciences Inc. stock compares with market leaders - July 2025 Decliners Daily Stock Trend Reports - Newser
12/02/2025
3
Aug Summary Can Precision BioSciences Inc stock hit analyst price targets - Weekly Trading Summary Reliable Breakout Stock Forecasts - moha.gov.vn
12/11/2025
4
Acquisition by Brown Melinda of 1381 shares of Precision BioSciences at 4.97 subject to Rule 16b-3
12/15/2025
5
Acquisition by Frankel Stanley of 2700 shares of Precision BioSciences at 4.7 subject to Rule 16b-3
12/16/2025
6
Insider Buying Precision BioSciences Director Acquires 12,690.00 in Stock - MarketBeat
12/17/2025
7
Acquisition by Michael Amoroso of 9443 shares of Precision BioSciences subject to Rule 16b-3
12/19/2025
8
Precision Biosciences Inc files for mixed shelf of up to 250 million - SEC filing - marketscreener.com
12/30/2025
9
Precision BioSciences Tiny Gene-Editing Stock Caught Between Deep Cuts and Big Optionality - AD HOC NEWS
01/05/2026
10
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGE...
01/12/2026
11
Aug Levels How does Precision BioSciences Inc perform in inflationary periods - 2025 Dividend Review Fast Gain Swing Alerts - baoquankhu1.vn
01/15/2026
12
Disposition of 2500 shares by Smith J. Jefferson of Precision BioSciences subject to Rule 16b-3
01/20/2026
13
Disposition of 10200 shares by Smith J. Jefferson of Precision BioSciences at 4.03 subject to Rule 16b-3
01/21/2026
14
Disposition of 34799 shares by Michael Amoroso of Precision BioSciences at 4.17 subject to Rule 16b-3
01/22/2026
15
Disposition of 964 shares by Michael Amoroso of Precision BioSciences at 5.56 subject to Rule 16b-3
01/27/2026
Begin Period Cash Flow116.7 M
Total Cashflows From Investing Activities-215 K

Precision BioSciences Relative Risk vs. Return Landscape

If you would invest  736.00  in Precision BioSciences on November 2, 2025 and sell it today you would lose (340.00) from holding Precision BioSciences or give up 46.2% of portfolio value over 90 days. Precision BioSciences is currently does not generate positive expected returns and assumes 3.8808% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than Precision, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Precision BioSciences is expected to under-perform the market. In addition to that, the company is 5.19 times more volatile than its market benchmark. It trades about -0.24 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Precision BioSciences Target Price Odds to finish over Current Price

The tendency of Precision Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.96 90 days 3.96 
about 83.1
Based on a normal probability distribution, the odds of Precision BioSciences to move above the current price in 90 days from now is about 83.1 (This Precision BioSciences probability density function shows the probability of Precision Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Precision BioSciences has a beta of 0.8 suggesting as returns on the market go up, Precision BioSciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Precision BioSciences will be expected to be much smaller as well. Additionally Precision BioSciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Precision BioSciences Price Density   
       Price  

Predictive Modules for Precision BioSciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Precision BioSciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.234.117.99
Details
Intrinsic
Valuation
LowRealHigh
3.5611.0614.94
Details
Naive
Forecast
LowNextHigh
0.023.907.78
Details
4 Analysts
Consensus
LowTargetHigh
29.5832.5036.08
Details

Precision BioSciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Precision BioSciences is not an exception. The market had few large corrections towards the Precision BioSciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Precision BioSciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Precision BioSciences within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.74
β
Beta against Dow Jones0.80
σ
Overall volatility
1.19
Ir
Information ratio -0.16

Precision BioSciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Precision BioSciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Precision BioSciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Precision BioSciences generated a negative expected return over the last 90 days
Precision BioSciences has high historical volatility and very poor performance
Precision BioSciences has high likelihood to experience some financial distress in the next 2 years
Precision BioSciences currently holds about 184.14 M in cash with (58.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66.
Latest headline from MacroaxisInsider: Disposition of 964 shares by Michael Amoroso of Precision BioSciences at 5.56 subject to Rule 16b-3

Precision BioSciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Precision Stock often depends not only on the future outlook of the current and potential Precision BioSciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Precision BioSciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding6.9 M
Cash And Short Term Investments86.3 M

Precision BioSciences Fundamentals Growth

Precision Stock prices reflect investors' perceptions of the future prospects and financial health of Precision BioSciences, and Precision BioSciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Precision Stock performance.

About Precision BioSciences Performance

By examining Precision BioSciences' fundamental ratios, stakeholders can obtain critical insights into Precision BioSciences' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Precision BioSciences is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.05  0.05 
Return On Capital Employed(0.25)(0.26)
Return On Assets 0.05  0.05 
Return On Equity 0.13  0.15 

Things to note about Precision BioSciences performance evaluation

Checking the ongoing alerts about Precision BioSciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Precision BioSciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Precision BioSciences generated a negative expected return over the last 90 days
Precision BioSciences has high historical volatility and very poor performance
Precision BioSciences has high likelihood to experience some financial distress in the next 2 years
Precision BioSciences currently holds about 184.14 M in cash with (58.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66.
Latest headline from MacroaxisInsider: Disposition of 964 shares by Michael Amoroso of Precision BioSciences at 5.56 subject to Rule 16b-3
Evaluating Precision BioSciences' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Precision BioSciences' stock performance include:
  • Analyzing Precision BioSciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Precision BioSciences' stock is overvalued or undervalued compared to its peers.
  • Examining Precision BioSciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Precision BioSciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Precision BioSciences' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Precision BioSciences' stock. These opinions can provide insight into Precision BioSciences' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Precision BioSciences' stock performance is not an exact science, and many factors can impact Precision BioSciences' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Precision BioSciences is a strong investment it is important to analyze Precision BioSciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Precision BioSciences' future performance. For an informed investment choice regarding Precision Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. Projected growth potential of Precision fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Precision BioSciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(8.96)
Revenue Per Share
0.069
Quarterly Revenue Growth
(0.98)
Return On Assets
(0.45)
Return On Equity
(2.05)
Precision BioSciences's market price often diverges from its book value, the accounting figure shown on Precision's balance sheet. Smart investors calculate Precision BioSciences' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Precision BioSciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Precision BioSciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Precision BioSciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.